Stay updated with breaking news from Nasdaq Idya. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Callan Capital LLC acquired a new position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,726 shares of the company’s stock, valued at approximately $239,000. Other hedge funds have also […]
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) fell 3.2% during trading on Thursday . The company traded as low as $38.88 and last traded at $38.90. 88,103 shares changed hands during mid-day trading, a decline of 90% from the average session volume of 847,028 shares. The stock had previously closed at $40.17. Analyst Ratings […]
IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its target price upped by Citigroup from $40.00 to $60.00 in a report published on Thursday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages have also recently issued reports on IDYA. Leerink Partnrs reiterated an outperform rating on shares […]
IDEAYA Biosciences, Inc. (NASDAQ:IDYA – Get Free Report) has been given an average recommendation of “Buy” by the thirteen analysts that are presently covering the firm, MarketBeat.com reports. Thirteen research analysts have rated the stock with a buy rating. The average twelve-month price objective among analysts that have issued ratings on the stock in the […]
IDEAYA Biosciences (NASDAQ:IDYA – Free Report) had its price objective boosted by JPMorgan Chase & Co. from $51.00 to $57.00 in a report issued on Friday, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. Several other research analysts have also weighed in on the company. Royal Bank of Canada […]